Metabolic Effects of Paricalcitol

NCT01003275 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Chronic Kidney Disease

Interventions

DRUG: Paricalcitol
DRUG: Placebo

Sponsor

University of Washington

Collaborators

[object Object]